Cargando…
IGF-1 in Friedreich’s Ataxia – proof-of-concept trial
BACKGROUND: Friedreich’s ataxia is an autosomal recessive, severely incapacitating disorder. There is little objective evidence regarding FRDA management. Abnormalities in the insulin/insulin-like growth factor 1 (IGF-1) system (IIS) signalling pathway were thought to play a role in the physiopathol...
Autores principales: | Sanz-Gallego, Irene, Torres-Aleman, Ignacio, Arpa, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552279/ https://www.ncbi.nlm.nih.gov/pubmed/26331034 http://dx.doi.org/10.1186/2053-8871-1-10 |
Ejemplares similares
-
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
por: Sanz-Gallego, Irene, et al.
Publicado: (2014) -
Depressive symptoms in Friedreich ataxia
por: Nieto, Antonieta, et al.
Publicado: (2018) -
Onset features and time to diagnosis in Friedreich’s Ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2020) -
Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893) -
The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)